8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (Nov 5, 2012)

Filed November 5, 2012For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on November 5, 2012, to announce its financial results for the third quarter ended September 30, 2012. The report primarily serves to furnish the accompanying press release detailing these results, as required by regulatory procedures. Investors should refer to the press release (Exhibit 99.1) for the specific financial performance and operational updates for the period. This filing does not contain substantial new operational or strategic information beyond the financial results themselves. The key takeaway for investors is the availability of the Q3 2012 financial data, which would typically include revenue, expenses, net income/loss, and cash flow information. The press release is the definitive source for these figures and any management commentary surrounding them.

Key Highlights

  • 1Alnylam Pharmaceuticals announced its financial results for the third quarter of 2012.
  • 2The announcement was made via a press release furnished as part of this 8-K filing.
  • 3The report is dated November 5, 2012, covering the period ending September 30, 2012.
  • 4The primary purpose of this filing is to provide investors with access to the Q3 2012 financial performance.
  • 5Information provided is deemed furnished, not filed, for purposes of certain SEC regulations.
  • 6Exhibit 99.1 contains the full press release with detailed financial results.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce and provide access to Alnylam Pharmaceuticals' financial results for the third quarter ended September 30, 2012, through an accompanying press release.

The detailed financial results for the third quarter of 2012 are available in the press release furnished as Exhibit 99.1 to this Form 8-K.

This specific 8-K filing primarily focuses on reporting financial results for the quarter. Any strategic updates or forward-looking guidance would typically be found within the content of the furnished press release (Exhibit 99.1), but the 8-K itself does not introduce new strategic information beyond that.

The information in this Form 8-K, including the furnished press release, is generally considered 'furnished' rather than 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means it may not be subject to the same liabilities as 'filed' information unless expressly incorporated by reference into a registration statement.